GLP-1 S CERTIFICATES OF ANALYSIS 14 COAs BN-26SM30-001 Current Variant: Size: 30mg Semaglutide 29.95 mg / 31.83 mg Purity 99.842% / 99.803% BN-26SM20-001 Current Variant: Size: 20mg-10ml Semaglutide 26 mg / 25.67 mg Purity 99.625% / 99.548% BN-26SM10-001 Current Variant: Size: 10mg Semaglutide 11.38 mg / 11.37 mg Purity 99.590% / 99.661% BN-26SM05-001 Current Variant: Size: 5mg Semaglutide 5.85 mg / 6.23 mg Purity 99.299% / 99.445% BN-26SM10-003 Upcoming Variant: Size: 10mg Semaglutide 11.85 mg / 11.49 mg Purity 99.590% / 99.605% BN-25SM1020-001 Previous Variant: Size: 10mg BN-25SM30-001 Previous Variant: Size: 30mg BN-25SM20-001 Previous Variant: Size: 20mg BN-25SM10-002 Previous Variant: Size: 10mg BN-25SM10-001 Previous Variant: Size: 10mg BN-25SM05-002 Previous Variant: Size: 5mg BN-25SM05-001 Previous Variant: Size: 5mg BN-25SM05-001 Previous Variant: Size: 5mg Small-Batch Research Confidence Focused research supply, documented batch by batch

Growing awareness of the long-term complications of uncontrolled diabetes, like neuropathy and cardiovascular disease, is also a critical aspect which further drives the demand for GLP-1 analogues
Eli Lilly structures Zepbound pricing at $349 monthly for starter doses and $499 monthly for standard doses
These medications, injected under the skin, work by regulating blood sugar levels and suppressing appetite, supporting short-term and long-term weight loss goals
In subjects without type 1 diabetes, insulin is secreted from the pancreas into the portal vein, where 50-80% of insulin is metabolized in the first hepatic pass
When these symptoms occur, they tend to be short-lived and vary between individuals